modafinil
Term · Oncology and biomedicine · MLC-T-ONC-005448
A drug that is being studied as a treatment for fatigue in patients with cancer. It belongs to the family of drugs called stimulants.
A synthetic central nervous system stimulant with wakefulness-promoting activity. Modafinil appears to inhibit dopamine reuptake, resulting in an increase in extracellular dopamine. This agent exhibits pronounced wakefulness-promoting activity (without sympathomimetic activity) and may improve cognitive function in certain clinical settings.
| Identifier | MLC-T-ONC-005448 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-005448",
"term": "modafinil",
"field": "Oncology and biomedicine",
"definitions": [
"A drug that is being studied as a treatment for fatigue in patients with cancer. It belongs to the family of drugs called stimulants.",
"A synthetic central nervous system stimulant with wakefulness-promoting activity. Modafinil appears to inhibit dopamine reuptake, resulting in an increase in extracellular dopamine. This agent exhibits pronounced wakefulness-promoting activity (without sympathomimetic activity) and may improve cognitive function in certain clinical settings."
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/modafinil/"
}
Record 11,159 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.